Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.2%

2 terminated out of 91 trials

Success Rate

90.5%

+4.0% vs benchmark

Late-Stage Pipeline

2%

2 trials in Phase 3/4

Results Transparency

21%

4 of 19 completed with results

Key Signals

4 with results90% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (21)
Early P 1 (1)
P 1 (3)
P 2 (3)
P 3 (1)
P 4 (1)

Trial Status

Recruiting35
Unknown19
Completed19
Enrolling By Invitation5
Not Yet Recruiting4
Active Not Recruiting4

Trial Success Rate

90.5%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (91)

Showing 20 of 20 trials
NCT06595940Recruiting

Genetic Analysis of Uncommon Disease Presentations in Non-US Populations

NCT04731857RecruitingPrimary

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

NCT07558213Active Not RecruitingPrimary

A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases

NCT03854318Recruiting

Longitudinal Studies of Patient With FPDMM

NCT07247279RecruitingPrimary

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

NCT07527624RecruitingPrimary

Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability

NCT06466109Not ApplicableCompletedPrimary

Using Social Robots in Children With Rare Diseases and Their Parents: A Feasibility Study

NCT06856902Not ApplicableRecruiting

BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe

NCT07497581Not Yet RecruitingPrimary

A Longitudinal Study on Family Adaptation and Relationship Dynamics in Pediatric Rare Diseases

NCT07247292SuspendedPrimary

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

NCT04654000Not ApplicableRecruiting

Rheopheresis as Adjuvant Treatment of Calciphylaxis

NCT07400913Not Yet RecruitingPrimary

Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases.

NCT02814747Not ApplicableCompletedPrimary

Evaluate and Understand Preferences and Representations in Families of Patients With Regard to High-throughput Sequencing Technology for Diagnostic Purposes

NCT07102966Not ApplicableRecruitingPrimary

Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas

NCT06573723RecruitingPrimary

Institutional Registry of Rare Diseases

NCT06285500Recruiting

Umbrella Study for Single Patient Treatments in Oncology

NCT04703179Enrolling By Invitation

Rare and Undiagnosed Disease Research Biorepository

NCT07063719Not ApplicableNot Yet RecruitingPrimary

Identification of Cellular Biomarkers of Rare Eye Diseases in Adults

NCT05179863RecruitingPrimary

Swiss Rare Disease Registry (SRDR)

NCT06612333Completed

Evaluation of the French Version of the PEERS Social Skills Training Program for Adolescents With Rare Neurodevelopmental Disorders

Scroll to load more

Research Network

Activity Timeline